Health Usha Lee McFarling Paying research participants — a lot — may be a key to increasing diversity in studies
Health Elaine Chen and Isabella Cueto 3 things to watch in chronic disease in 2023: obesity drugs, long Covid and health care costs
Health Ryan Cross — The Boston Globe Drug companies set sights on new Covid medicines to boost depleted arsenal
Health Helen Branswell Three years on, the pandemic — and our response — have been jolting. Here’s what even the experts didn’t see coming
Health Ambar Castillo U.S. life expectancy falls for second straight year as drug overdose and Covid deaths take toll
Health Jason Mast Infectious disease board recommends hospitals stop screening asymptomatic patients for Covid-19
Politics Rachel Cohrs and Sarah Owermohle Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness
Biotech Jason Mast Drugmakers ask regulators to change standards on new Covid antibody drugs for most vulnerable
Health Tara Bannow Nine in 10 health care companies with financial stress are owned by private equity
Health Elizabeth Cooney Death certificate records of long Covid are a ‘floor of an estimate,’ experts say
Pharmalot Ed Silverman Lawmakers tell Pfizer CEO to ‘back off’ on planned price hike for Covid-19 vaccine
Health Isabella Cueto Getting ahead of ‘tsunami’ of chronic disease will require data and creativity, experts say
Politics Rachel Cohrs Walensky says CDC needs more authority from Congress to collect public health data
Business Tara Bannow Medical malpractice lawsuits, delayed by the pandemic, are hitting hospitals harder than expected
Health Andrew Joseph Covid evolution wipes out another antibody treatment, threatening the country’s medicine cabinet
Health Helen Branswell With no exit strategy from ‘zero Covid’ policy, China could face tsunami in cases, experts fear